Elon Musk renewed his longstanding feud with the Securities and Exchange Commission on Thursday by posting a letter that said ...

The US Securities and Exchange Commission (SEC) has reopened its investigation into Neuralink, Elon Musk’s brain-implant ...

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

The US Securities and Exchange Commission (SEC) has reopened its investigation into Neuralink, Elon Musk’s brain-implant company, alongside a probe into Musk’s acquisition of Twitter ...

A letter from the Tesla and SpaceX CEO's attorney says the regulator has also reopened an investigation into his Neuralink ...

The US Securities and Exchange Commission (SEC) has opened an investigation into Neuralink, the brain implant company owned by Elon Musk. The billionaire published a letter from his lawyer Alex ...

Tech investor Apoorv Agrawal has described Neuralink as the “most important company of the decade.” The bold claim on X has sparked widespread attention, but it was Elon Musk’s repost that ...

Elon Musk has revealed that Neuralink, his brain-chip implant company, is facing a probe from the Securities and Exchange Commission, with which he has long feuded. Musk posted a letter on the ...

The U.S. Securities and Exchange Commission has reopened an investigation into Elon Musk's brain-chip startup Neuralink, ...

There's little information on the product yet and, as is often the case with Neuralink developments, the main source of news is Elon Musk himself via his X.com platform (formerly Twitter).